NDC 50114-7055

Placenta Compositum

Horse Chestnut And Lactic Acid, L- And Claviceps Purpurea Sclerotium And Cupric Sulfate And Melilotus Officinalis Top And Sus Scrofa Placenta And Solanum Nigrum Whole And Strophanthus Hispidus Seed And Sus Scrofa Embryo And Sodium Pyruvate And Sus Scrofa Vein And Sus Scrofa Artery And Sus Scrofa Umbilical Cord And Tobacco Leaf And Vipera Berus Venom And Barium Carbonate And Lead Iodide

Placenta Compositum is a Intradermal; Intramuscular; Intravenous; Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Heel Inc. The primary component is Horse Chestnut; Lactic Acid, L-; Claviceps Purpurea Sclerotium; Cupric Sulfate; Melilotus Officinalis Top; Sus Scrofa Placenta; Solanum Nigrum Whole; Strophanthus Hispidus Seed; Sus Scrofa Embryo; Sodium Pyruvate; Sus Scrofa Vein; Sus Scrofa Artery; Sus Scrofa Umbilical Cord; Tobacco Leaf; Vipera Berus Venom; Barium Carbonate; Lead Iodide.

Product ID50114-7055_cc3f0e8b-fc8c-4a62-b3e7-d70b061977e4
NDC50114-7055
Product TypeHuman Prescription Drug
Proprietary NamePlacenta Compositum
Generic NameHorse Chestnut And Lactic Acid, L- And Claviceps Purpurea Sclerotium And Cupric Sulfate And Melilotus Officinalis Top And Sus Scrofa Placenta And Solanum Nigrum Whole And Strophanthus Hispidus Seed And Sus Scrofa Embryo And Sodium Pyruvate And Sus Scrofa Vein And Sus Scrofa Artery And Sus Scrofa Umbilical Cord And Tobacco Leaf And Vipera Berus Venom And Barium Carbonate And Lead Iodide
Dosage FormInjection
Route of AdministrationINTRADERMAL; INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2009-04-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameHeel Inc
Substance NameHORSE CHESTNUT; LACTIC ACID, L-; CLAVICEPS PURPUREA SCLEROTIUM; CUPRIC SULFATE; MELILOTUS OFFICINALIS TOP; SUS SCROFA PLACENTA; SOLANUM NIGRUM WHOLE; STROPHANTHUS HISPIDUS SEED; SUS SCROFA EMBRYO; SODIUM PYRUVATE; SUS SCROFA VEIN; SUS SCROFA ARTERY; SUS SCROFA UMBILICAL CORD; TOBACCO LEAF; VIPERA BERUS VENOM; BARIUM CARBONATE; LEAD IODIDE
Active Ingredient Strength4 [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL; [hp_X]/2.2mL
Pharm ClassesOsmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Non-Standardized Plant Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Allergens [CS],Plant Proteins [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 50114-7055-1

10 VIAL in 1 CARTON (50114-7055-1) > 2.2 mL in 1 VIAL
Marketing Start Date2009-04-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50114-7055-1 [50114705501]

Placenta Compositum INJECTION
Marketing Categoryunapproved homeopathic
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-04-30
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
HORSE CHESTNUT4 [hp_X]/2.2mL

OpenFDA Data

SPL SET ID:481bd51c-afc6-4b33-abce-6f94ef6b1483
Manufacturer
UNII

Pharmacological Class

  • Osmotic Laxative [EPC]
  • Increased Large Intestinal Motility [PE]
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
  • Osmotic Activity [MoA]
  • Non-Standardized Plant Allergenic Extract [EPC]
  • Increased Histamine Release [PE]
  • Cell-mediated Immunity [PE]
  • Increased IgG Production [PE]
  • Allergens [CS]
  • Plant Proteins [CS]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.